I am Professor of Psychiatry, Associate Head of Department (Research), and Chair of the University of Oxford Neuroscience Committee. I trained in Oxford and London, and was a Wellcome Trust Senior Research Fellow before being appointed to my present post in 1997. I head a research group investigating molecular, psychopharmacological and therapeutic aspects of mood disorders and schizophrenia – and now the neuropsychiatric aspects of COVID-19. I have published 350 papers and several books. My clinical work centres on mood disorders. I am a Deputy Editor for Biological Psychiatry. I have served on various funding committees, chaired an NHS Research Ethics Committee, and was Treasurer for the Academic Faculty of the Royal College of Psychiatrists. I have supervised 24 PhDs. Awards include the CINP/Paul Janssen Schizophrenia Prize (1998), the British Association for Psychopharmacology Senior Clinical Prize (1999), the A.E. Bennett Award of the Society of Biological Psychiatry (2004), the Joel Elkes Research Award of the American College of Neuropsychopharmacology (2005), the CINP Lilly Clinical Neuroscience award (2010), and the ECNP Clinical Neuropsychopharmacology award (2012). I was President of the British Association for Psychopharmacology from 2014-2016.